A detailed history of Ninety One North America, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Ninety One North America, Inc. holds 198,906 shares of JNJ stock, worth $30.9 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
198,906
Previous 308,676 35.56%
Holding current value
$30.9 Million
Previous $45.1 Million 28.55%
% of portfolio
2.22%
Previous 2.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $16 Million - $18.4 Million
-109,770 Reduced 35.56%
198,906 $32.2 Million
Q2 2024

Jul 22, 2024

SELL
$144.38 - $157.78 $6.36 Million - $6.95 Million
-44,063 Reduced 12.49%
308,676 $45.1 Million
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $1.73 Million - $1.82 Million
-11,154 Reduced 3.07%
352,739 $55.8 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $10.3 Million - $11.2 Million
-70,679 Reduced 16.26%
363,893 $57 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $6.17 Million - $6.92 Million
-39,635 Reduced 8.36%
434,572 $67.7 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $574,490 - $618,261
-3,722 Reduced 0.78%
474,207 $78.5 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $153,013 - $182,603
-1,013 Reduced 0.21%
477,929 $74.1 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $7.74 Million - $8.69 Million
-48,310 Reduced 9.16%
478,942 $84.6 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $1.5 Million - $1.67 Million
-9,321 Reduced 1.74%
527,252 $86.1 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $4.21 Million - $4.66 Million
25,045 Added 4.9%
536,573 $95.2 Million
Q1 2022

Apr 27, 2022

BUY
$158.14 - $179.59 $2.65 Million - $3.01 Million
16,735 Added 3.38%
511,528 $90.7 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $15.7 Million - $17.4 Million
100,611 Added 25.52%
494,793 $84.6 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $5.16 Million - $5.74 Million
31,972 Added 8.83%
394,182 $63.7 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $12.5 Million - $13.4 Million
78,449 Added 27.65%
362,210 $59.7 Million
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $722,949 - $805,177
-4,723 Reduced 1.64%
283,761 $46.6 Million
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $18.1 Million - $20.7 Million
131,766 Added 84.08%
288,484 $45.4 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $9.91 Million - $10.9 Million
70,565 Added 81.91%
156,718 $23.3 Million
Q2 2020

Aug 20, 2020

BUY
$128.81 - $155.51 $5.12 Million - $6.18 Million
39,713 Added 85.51%
86,153 $12.1 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $19 Million - $23 Million
-147,773 Reduced 76.09%
46,440 $6.77 Million
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $16.4 Million - $22.8 Million
147,773 Added 318.2%
194,213 $25.5 Million
Q4 2019

Feb 07, 2020

BUY
$127.5 - $146.44 $336,090 - $386,015
2,636 Added 6.02%
46,440 $6.77 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $174,048 - $194,873
-1,371 Reduced 3.03%
43,804 $5.67 Million
Q2 2019

Jul 30, 2019

SELL
$131.15 - $144.24 $862,573 - $948,666
-6,577 Reduced 12.71%
45,175 $6.29 Million
Q1 2019

Apr 24, 2019

BUY
$125.72 - $139.79 $422,922 - $470,253
3,364 Added 6.95%
51,752 $7.23 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $3.82 Million - $4.6 Million
-31,099 Reduced 39.12%
48,388 $6.24 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $1.05 Million - $1.23 Million
-8,596 Reduced 9.76%
79,487 $11 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $741,832 - $818,624
6,213 Added 7.59%
88,083 $10.7 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $5.48 Million - $6.49 Million
43,833 Added 115.24%
81,870 $10.5 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $2.84 Million - $3.1 Million
21,610 Added 131.55%
38,037 $5.32 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $2.13 Million - $2.22 Million
16,427
16,427 $2.14 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ninety One North America, Inc. Portfolio

Follow Ninety One North America, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ninety One North America, Inc. with notifications on news.